Ré Labo First Exosome Based Home Treatment in Malaysia

Ré Labo First Exosome Based Home Treatment in Malaysia for skin rejuvenation with advanced Stem Cell Technology by Revery International. This groundbreaking anti-aging solution harnesses stem cell-derived exosomes combined with potent skincare components to offer a revolutionary at-home treatment. 

Ré Labo First Exosome Based Home Treatment in Malaysia

With ReLabo as their source of reassurance, Malaysians can now access non-invasive, science-backed skincare solutions designed to deliver visible results without the need for surgery or downtime. Globally, the anti-aging market is rapidly growing, which leads to the need for non-invasive treatments that provide professional results at home to be higher. 

Ré Labo Official Launch by Revery International at The MET

Recognising that this demand is growing and that the consumer demographic seeking anti-aging solutions is becoming younger particularly among consumers aged 26 to 35, REVERY International has invested more than RM5 million in research and development to create the safest and most effective solutions for anti-aging. 

As a global leader in biomedical research and innovation, REVERY International is on the rise, bringing new developments to the beauty and wellness industry. Ms Tiffany Loh, Founder and CEO of REVERY International, expressed that ReLabo represents a significant leap in biotechnology and skincare innovation, improving the quality of life for those seeking effective, science-backed skincare solutions.

As the first Exosome-based home treatment, ReLabo's focuses on the concept of "anti-premature aging" by utilising the advanced biotechnology to effectively address skin aging issues cause by harsh lifestyle, stress, environmental factors and even UV exposure. 

ReLabo by REVERY offers a new direction in skin rejuvenation, elevating REVERY's position in the medical-aesthetic industry and opening new opportunities. As an elite "Anti-Premature Aging" brand tailored for the discerning urbanites, ReLabo utilises cutting-edge Exosome technology from stem cells to tackle the initial signs of aging. 

Dr Malcolm Lee, Medical Director of REVERY International highlighted that this innovative approach simplifies the anti-aging process, empowering individuals to maintain their youthful allure. 

Starting July 2024, REVERY International will launch a comprehensive medical health centre, focusing on cardiac health evaluations and professional health consultations. This marks REVERY International's strategic foray into the healthcare sector, leveraging the latest in medical technology to provide advanced healthcare services. 

With a steadfast commitment to excellence, REVERY anticipates the positive impact of these initiatives. Visit https://www.revery.group/ for more information and updates on REVERY International